Development and Application of a Stage-Based Management Protocol for Sarcopenia in Esophageal Cancer Patients Based on an Evidence Ecosystem.

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2500105304

Enrollment

Unknown

Registered

2025-07-01

Start date

2025-07-01

Completion date

Unknown

Last updated

2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer

Interventions

Control group:Conventional treatment and care.

Intervention group:Phased management of esophageal cancer-associated sarcopenia based on an evidence ecosystem.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. A pathological diagnosis confirming esophageal cancer, staged as 0, I, II, or III; 2. Age >= 18 years; 3. Understanding the purpose of the research and expressing a willingness to participate in this investigation; 4. Having undergone or being scheduled for surgical treatment of esophageal cancer.

Exclusion criteria

Exclusion criteria: 1. Unaware of the diagnosis of esophageal cancer; 2. Diagnosed with cognitive impairment or psychological and psychiatric disorders; 3. Experiencing changes in condition or accompanied by other severe comorbidities.

Design outcomes

Primary

Measure	Time frame
Sarcopenia screening and diagnosis.;Nutritional indicators.;	—

Secondary

Measure	Time frame
Compliance with physical exercise and adherence to nutritional practices.;Quality of life;Cancer-related fatigue;	—

Countries

China

Contacts

Public ContactSuhua Zeng

The first affiliated hostipal of nanchang university

401752724@qq.com+86 152 7082 9663

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026